GROW WITH US
Why UIZ.CARE Is Investable Now
UIZ.CARE is a clinical-grade, AI-enabled primary-care infrastructure company designed for Generation Z and their General Practitioners. It is not another mental-health app. It is built to help primary care recognize distress earlier, structure intake and triage more effectively, and create a stronger front door into youth mental-health support. Its architecture combines youth engagement, GP workflow support, and institutional analytics in one payer-aligned model.
What makes UIZ.CARE investable now is that a meaningful share of the hardest early-stage work in healthcare innovation has already been completed. The company has moved beyond concept validation through pilot execution, implementation learning, product refinement, and early compliance and evidence structuring. As a result, the next phase is no longer about testing whether the problem exists. It is about converting validated groundwork into product maturity, regulatory progression, evidence depth, and structured commercialization.
The market need is structural and persistent. Youth mental health remains one of the most underserved and operationally difficult areas in primary care. Young people often present late, underreport distress, or move between informal support and clinical need without continuity. At the same time, GPs face rising workload pressure, fragmented pathways, and limited consultation time. This creates a clear need for workflow-embedded solutions that improve signal capture, support earlier intervention, and reduce avoidable referral leakage without adding operational complexity.
UIZ.CARE is positioned inside that gap. Its model is built around structured care workflows, explainable emotional-health intelligence, and reimbursement-oriented deployment. The company is pursuing staged commercialization with a strategy focused on compliance, evidence generation, and payer-aligned contracting rather than unregulated growth. Seed capital is intended to finalize MDR and EU AI Act readiness, complete key AI modules and integrations, strengthen regulatory, clinical, and commercial capacity, and activate structured commercialization in the Netherlands with groundwork for Germany and Benelux.
From an investor perspective, UIZ.CARE sits at an attractive inflection point: the risk profile has improved materially through prior work, while the largest value creation opportunities still lie ahead in market entry, institutional contracting, and long-term defensibility. That defensibility is expected to emerge not only from product features, but from the combination of workflow integration, real-world implementation insight, evidence generation, interoperability, regulatory preparation, and payer alignment.
UIZ.CARE is therefore not raising capital to preserve an idea. It is raising capital to accelerate a transition already underway: from completed pilot groundwork to a scalable, institutionally credible digital health company operating at the intersection of youth well-being, prevention, AI-supported care structuring, and primary care transformation.
Investment thesis
UIZ.CARE is investable now because it has already completed a substantial share of the non-obvious groundwork required in regulated healthcare innovation and is entering the stage where capital can unlock disproportionate value through product consolidation, evidence maturity, regulatory readiness, and disciplined market-entry execution.
